J0879 – Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ0879
- Long description
- Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)
- Short description
- Difelikefalin, esrd on dialy
- Pricing indicator
57Other carrier priced- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- Added
- April 1, 2022
- Last change
- January 1, 2024 – No change
Frequently asked questions
What is HCPCS code J0879?
J0879 is a HCPCS Level II code for injection, difelikefalin, 0.1 microgram, (for esrd on dialysis).
Does Medicare cover J0879?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J0870 – Injection, imetelstat, 1 mg
- J0871 – Injection, daptomycin (endo), not therapeutically equivalent to j0878, 1 mg
- J0872 – Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg
- J0873 – Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg
- J0874 – Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg
- J0875 – Injection, dalbavancin, 5 mg
- J0877 – Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mg
- J0878 – Injection, daptomycin, 1 mg
- J0881 – Injection, darbepoetin alfa, 1 microgram (non-esrd use)
- J0882 – Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)
- J0883 – Injection, argatroban, 1 mg (for non-esrd use)
- J0884 – Injection, argatroban, 1 mg (for esrd on dialysis)
- J0885 – Injection, epoetin alfa, (for non-esrd use), 1000 units
- J0886 – Injection, epoetin alfa, 1000 units (for esrd on dialysis)
- J0887 – Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
- J0888 – Injection, epoetin beta, 1 microgram, (for non esrd use)
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.